Communication with the FDA on a Development Pathway for Cell Therapy Products: Why, What, When and How

Pharmaceutical, Biotechnology and Medical Device Industries Partner Michael Werner will speak at the Bio International Convention on three panels that include, "Communication with the FDA on a Development Pathway for Cell Therapy Products:  Why, What, When and How", "Talk to Me: How Effective FDA/Sponsor Interactions Can Help Commercialize Cell-based Therapies" and "Human Subject Protections in the United States".